Third Quarter 2025 Net Revenues of $1.2 Million, Gross Profit of $.6 Million and Gross Margin of 51% New Pro-U.S. Border Security Administration Provides Additional Macro Tailwinds for 2025 & Beyond with Validated Pipeline of $166 Million Raised $9.7 Million in Aggregate Proceeds from the Exercise of Warrants Subsequent to Quarter End, Fortifying Balance Sheet and Providing Additional Operational and Financial Flexibility REDMOND, Wash., Nov. 17, 2025 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, today reported its financial and operational results for the third quarter ended September 30, 2025. Q3 2025 Financial HighlightsNet revenues for the quarter ended September 30, 2025, were $1.2 million....

CHICAGO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today reported financial results for the third quarter and nine-month period ended September 30, 2025. Financial Highlights for the Three and Nine Months Ended September 30, 2025 Income StatementCosmos Health delivered a record quarter, achieving the highest revenue, gross profit, and gross margin in its history, along with a significant improvement in adjusted profitability. These results were driven by record-breaking performance across all core business segments, including the continued ramp-up of the contract manufacturing division at Cana Laboratories (“Cana”), strong sales through Decahedron in the United Kingdom, robust growth in the CosmoFarm...

ATHENS, Greece, Nov. 17, 2025 (GLOBE NEWSWIRE) — Euroholdings Ltd (NASDAQ: EHLD, the “Company” or “Euroholdings”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the three and nine-month periods ended September 30, 2025. The Company was incorporated by Euroseas Ltd. (NASDAQ: ESEA, or “Euroseas”) to serve as the holding company of three subsidiaries that were contributed by Euroseas to Euroholdings effective January 1, 2025; Euroseas spun-off Euroholdings on March 17, 2025, which has since been operated as an independent company. The results below refer to Euroholdings and its subsidiaries for the periods presented. Historical comparative periods reflect the results of the carve-out operations of the three vessels that...

SARASOTA, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced third quarter 2025 financial results. Q3 2025 Financial Highlights (all metrics compared to Q3 2024 unless otherwise noted)Revenue was $1,757,094, an increase of 23% compared to $1,433,151. Consolidated clinic revenue from the Company’s INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin, increased 21% to $1,722,223, compared to $1,418,011. Revenue from all clinics, including both consolidated and equity method clinics, was $1,995,007, an increase of 18% compared to $1,686,093. Net loss was $(2.6) million compared to...

Export growth and margin improvement drive continued performance SINGAPORE, Nov. 17, 2025 (GLOBE NEWSWIRE) — HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Singapore-based home furniture company with sales across Asia-Pacific, Europe and North America, today announced its unaudited financial results for the nine months ended September 30, 2025 (“9M 2025”) and the third quarter of 2025 (“Q3 2025”). “Our consistent performance demonstrates the resilience of our diversified export model and disciplined cost control,” said Ms. Phua Mei Ming, Chief Executive Officer of HomesToLife. “As we approach the year-end peak season, we are well-positioned to capitalize on seasonal demand while sustaining long-term growth through our key markets.”Selected Financial Highlights                                         9M...

Record Financial Performance Highlights Expansion of Integrated Energy Platform Across New Markets Operational Execution Drives Gross Profit Margins to 11% MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, stored, and delivered, today announced financial results for the third quarter ended September 30, 2025, reflecting the company’s strongest financial performance to date and continued momentum in scaling its multi-revenue energy platform. Selected Financial & Operational HighlightsMetric Q3 2025 (unaudited) Q3 2024 (unaudited)Revenue $22.9M $6.9MGross Profit $2.4M $0.6MStock Based Compensation $(5.6M) $(0.02M)Loss from Operations $(9M) $(2.9M)Net Loss $(14.9M) $(10.6M)“Our third quarter performance reflects...

Fourth quarter Operating Income of $11.5 million and Adjusted Operating Income of $37.7 million Fourth quarter Net Earnings of $11.4 million and Adjusted EBITDA of $57.4 million Fourth quarter EPS of $0.58 and Adjusted EPS of $1.58 MOUNT LAUREL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) — J & J Snack Foods Corp. (Nasdaq: JJSF) (the “Company”) today reported financial results for the fourth quarter and full year ended September 27, 2025.  Fourth Quarter Full YearActuals % vs. LY Actuals % vs. LYNet Sales $410.2M -4 % $1,583.2M 1 %Gross Profit $130.2M -4 % $469.9M -3 %Operating Income $11.5M -71 % $84.3M -28 %Net Earnings $11.4M -62 % $65.6M -24 %Earnings per Diluted Share $0.58 -62 % $3.36 -24 %         Adjusted Operating Income $37.7M -10 % $108.2M -17 %Adjusted EBITDA $57.4M -4 % $180.9M -10 %Adjusted...

Strong Quarter Highlighted by Advancing the Company’s International Expansion Strategy FT. LAUDERDALE, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update. Yossef Balucka, Chief Executive Officer of Duke Robotics, commented: “The third quarter of 2025 marked meaningful progress in advancing our international expansion strategy. We strengthened our operations in Greece and achieved significant milestones across our defense and civilian business lines. On the defense and civilian fronts, we’re encouraged by growing government focus on drone technologies worldwide, highlighted...

NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive correspondence from FDA, and expects Q2 2026 GDUFA date. HOPE Therapeutics is now operating three revenue-generating facilities in Florida and expects six or more by year-end providing neuroplastic drugs, transcranial magnetic stimulation, hyperbaric therapy, and digital therapeutics to treat suicidal depression and PTSD. NRx has secured operating capital anticipated to be sufficient for drug development operations through July 2026. The Company additionally expects to increase revenue from clinical operations. NRx received FDA grant of Fast Track Designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. New Real-World Data support the effect of D-cycloserine...

ENGLEWOOD CLIFFS, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) — Atlantic International Corp. today announced continued operational momentum in its third-quarter 2025 results, reflecting a meaningful shift in the company’s financial trajectory and a significant improvement in year-to-date performance. For the first nine months of 2025, the company achieved $315.8 million in service revenue, supported by a record quarter that delivered $110.1 million in revenue, a 2.2% increase over the same period last year. This steady growth reflects sustained demand across a highly satisfied and referenceable client base. Atlantic International’s financial turnaround is most evident in its bottom-line results. The company narrowed its nine-month net loss to $32.3 million, or $0.59 per share, compared to $66.8 million, or $2.04 per share,...